DEMETER HOUSE
Demeter House offers medically monitored and clinically managed intensive residential treatment services for adult women. Our female only rehab center provides women a safe, supported, and comfortable environment. This intensive residential program helps break the cycle of drug and alcohol misuse and equips women with the tools needed to be successful in recovery.
Watch to learn more about Demeter House
This nationally accredited program includes the following services:
Trauma Informed Care
Medication Assisted Treatment
Use of Evidence Based Practices
24/7 Care
Individual Counseling
Group Counseling
Daily Exercise
Psychoeducation
Additional Medical and Mental Health Care as Needed
Family Involvement as Indicated
Linkage to Community Recovery Support Systems
Need Help?
Schedule a confidential assessment
Call us at (703) 841-0703, option 1
Leadership
for Demeter House
Rebecca Black, MSW, LCSW
Deputy Director of Clinical Operations
-
Rebecca Black has currently started a new role as Deputy Director of Clinical Operations in which she will work closely with the Director of Clinical Operations to oversee National Capital’s residential programs.
Previous to this role, she was the program director for Demeter House. In that position, she was responsible for clinical operations of Demeter House, NCTR’s residential program for women, to assure that high quality treatment services are provided to all patients.
Prior to joining National Capital Treatment & Recovery, she worked for seven years as an inpatient clinical manager at Pathways-Luminis Health in Maryland.
She is a licensed clinical social worker with 13 years of experience in the substance use disorder treatment field. She has a Master of Social Work degree from the University of Maryland, Baltimore. She is also an Adjunct Professor at Anne Arundel County Community College, in Maryland.
Fatima Urias, CSAC-A.
Residential Supervisor
-
Fatima Urias Salinas is the Residential Supervisor at Demeter House, where she leads daily residential operations to create a safe, structured environment that supports women in recovery. Her leadership is key to building trust and fostering healing in a setting where compassionate care is essential.
Her background in residential substance use treatment—including managing client care across various levels (3.5, 3.1, and 2.5 programs)—has provided her with advanced skills in crisis intervention and structured programming. This expertise directly informs recovery strategies that empower clients to rebuild their lives.
Fatima’s diverse experience also encompasses emergency response and public safety. At Randolph-Macon College, she served as a Resident Assistant, Campus Safety PD Dispatcher, and Emergency Response Team Member. These roles honed her crisis management and emergency response skills. Additionally, her early childhood education background enhances her ability to create nurturing, resilient environments that are vital for residential treatment.
Ama Boateng, DNP, APRN, PMHNP-BC, FNP-C
Medical Manager
-
Ama is a board-certified Nurse practitioner with a doctorate in nursing practice who specializes in Family and Psychiatry from George Washington University. She believes that empathy and building a trusting relationship with patients and their families are vital to any recovery process across lifespan.
Mary Lee, MD
Medical Consultant
-
Dr. Mary Lee received her medical degree from Columbia University College of Physicians and Surgeons in 1989. She completed her residency in internal medicine at Columbia Presbyterian Medical Center and subsequently completed a psychiatric residency at George Washington University. Dr. Lee is board-certified in psychiatry, internal medicine, and addiction medicine.
She joined the CPN laboratory in November 2012. Her research has focused on the effect of intranasal oxytocin on drug craving, reward learning, and emotional processing in drug-dependent and schizophrenic patients. In addition, she has investigated the neurobehavioral effects of genetic polymorphisms, COMT and OPRM, on reward processing in smokers and drug users.
Her current research explores the role of oxytocin in alcohol and drug use disorders. She was the principal investigator of a translational and clinical project studying the role of oxytocin in alcohol use disorder, for which she received an NIH Bench-to-Bedside (B2B) Award from the Office of Behavioral & Social Sciences Research (OBSSR). She is also collaborating with George Mason University on a project funded by the Department of Defense, aimed at investigating the role of oxytocin in long-term bonding.
In 2018, Dr. Lee was presented with the NIAAA Clinical Service Award.